Cargando…
Iron(iii) chelated paramagnetic polymeric nanoparticle formulation as a next-generation T(1)-weighted MRI contrast agent
Magnetic resonance imaging (MRI) is a routinely used imaging technique in medical diagnostics. To enhance the quality of MR images, contrast agents (CAs) are used, which account for nearly 40% of MRI exams in the clinic globally. The most used CAs are gadolinium-based CAs (GBCAs) but the use of GBCA...
Autores principales: | Marasini, Ramesh, Rayamajhi, Sagar, Moreno-Sanchez, Anthony, Aryal, Santosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041822/ https://www.ncbi.nlm.nih.gov/pubmed/35495502 http://dx.doi.org/10.1039/d1ra05544e |
Ejemplares similares
-
Indocyanine-type Infrared-820 Encapsulated Polymeric
Nanoparticle-Assisted Photothermal Therapy of Cancer
por: Marasini, Ramesh, et al.
Publicado: (2022) -
Conformational Stability Effect of Polymeric Iron Chelators
por: Qian, Jian, et al.
Publicado: (2019) -
Highly hydrated paramagnetic amorphous calcium carbonate nanoclusters as an MRI contrast agent
por: Dong, Liang, et al.
Publicado: (2022) -
Properties of Paramagnetic Metals in MRI
por: Schaefer, Michel
Publicado: (1997) -
Advances in iron chelation therapy: transitioning to a new oral formulation
por: Shah, Nirmish R.
Publicado: (2017)